Sanofi Drug Shortages & Jazz Acquires Actio: Pharma News
Sanofi is experiencing active shortages of Myozyme and Nexviazyme, two critical enzyme replacement therapies used to treat Pompe disease, according to reporting by STAT. The supply chain disruption emerged shortly after the U.S. Food and Drug Administration issued a warning letter to the drugmaker regarding manufacturing issues at its Irish production facility in Waterford. Manufacturing … Read more